Machine learning methods to predict amyloid positivity using domain scores from cognitive tests

Abstract Amyloid- $$\beta$$ β (A $$\beta$$ β ) is the target in many clinical trials for Alzheimer’s disease (AD). Preclinical AD patients are heterogeneous with regards to different backgrounds and diagnosis. Accurately predicting A $$\beta$$ β status of participants by using machine learning (ML)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Guogen Shan, Charles Bernick, Jessica Z. K. Caldwell, Aaron Ritter
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ea894322e2e844929f1099088cdfa50c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!